Immupharma Plc
- Biotech or pharma, therapeutic R&D
Lupuzor ™ is the company’s most advanced drug candidate and is a treatment for lupus. Lupuzor ™ has 'Gold Standard' approval from the US FDA for its Phase III trial with a Special Protocol Assessment and "Fast Track"designation. Lupuzor ™ has now commenc
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}